Equibal Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Equibal

Access the complete profile.

Equibal Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	621511 Medical Laboratories
Additional NAICS Codes	424 Merchant Wholesalers, Nondurable Goods
Address	P.o Box 180 Unionville, NY 10988

Note: Revenues for privately held companies are statistical evaluations.


Equibal's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Equibal's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Equibal is classified as operating in the Medical Laboratories industry, NAICS Code 621511.

Equibal Annual Revenue and Growth Rate

Equibal	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Equibal's revenues are gauged from an analysis of company filings.

Equibal's Income Statement (based on Industry Averages)

Equibal P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Equibal is developing and marketing. Equibal doesn't have any recent trademark applications, indicating Equibal is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
M M hair shampoo, body wash, skin moisturizer, skin lotion, body lotion, moisturizing body lotions, splash skin toner	05/16/2020
QUICKMEND Antiseptic preparations; Cold sore treatment preparations; Fever blister treatment preparations; Topical analgesics	11/29/2015
EQUIFECT All purpose disinfectants; All purpose disinfectants for hard nonporous surfaces, brushese, combs, manicure implements, scissors, and stainless steel implements; Antibacterial cleaners; Antibacterial substances for medical purposes; Disinfectants for hygiene purposes; Disinfectants for medical instruments; Germicides and fungicides; Virucides	11/29/2015

See all trademarks and details in the Full Report.

Market Share of Equibal's Largest Competitors

A competitive analysis shows these companies are in the same general field as Equibal, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
PHYSICIANS IMMUNODIAGNOSTIC LABORATORY	Burbank, CA	100
ACCU REFERENCE MEDICAL LAB LIMITED LIABILITY	Linden, NJ	100
CENTOGENE US	Cambridge, MA	88
LATARA ENTERPRISE	Pomona, CA	61
TELIGENT PHARMA	Vineland, NJ	46
COVID CLINIC	Huntington Beach, CA	37
VIKOR SCIENTIFIC	Charleston, SC	33
BIOTHERANOSTICS	San Diego, CA	31
SHERMAN-ABRAMS LABORATORY	Brooklyn, NY	31

Nearby Competitors

These companies are similar in business line and location to Equibal. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
PARTNERS IN SAFETY	Middletown, NY	100
THIRD AVENUE IMAGING	Monroe, NY	48
DANIEL J OCONNELL	New City, NY	38
EQUIBAL	Unionville, NY	37
AMEICAN BIOSCIENCES	Blauvelt, NY	31
ALLCARE AMBULETTE	Spring Valley, NY	5

Future Competition: Equibal's Fastest Growing Competitors

These companies are in the same general field as Equibal and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)